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Lately, advances in high-throughput technologies in biomedical
research have led to a dramatic increase in the accessibility of
molecular insights at multiple biological levels in hepatology.
Much of this information is available in publications, but an
increasing number of large-scale analyses are currently being
stored in databases. Scopes of these databases are very divergent
and may range from large, general databases collecting informa-
tion on almost every known disease, to very specialized
databases covering only a speciﬁc liver disease or aspect of hepa-
tology. Over recent years, these bioinformatics data repositories
have rapidly evolved into an essential aid for molecular hepatol-
ogy. However, although publicly available through the internet,
many of these databases are only known to a few experts. To
facilitate access to these resources, the publicly available
databases supporting research on liver diseases are summarized
in this review.
 2014 European Association for the Study of the Liver. Published
by Elsevier B.V. Open access under CC BY-NC-ND license.Introduction
Chronic liver disease is a major health burden worldwide. In
developed countries, viral hepatitis B and C [1], but also NALFD/
NASH [2,3], result in a steadily increasing number of patients
with liver ﬁbrosis, cirrhosis or hepatocellular carcinoma as
common end-stage [4].
Recent advances in drug development for viral hepatitis will
certainly be beneﬁcial for many patients [5]. However, for
patients with liver ﬁbrosis, cirrhosis or hepatocellular carcinoma,
only very few drugs, if any, are currently available [6,7]. Thus,
investigating the molecular causes of chronic liver diseases, but
also their common end-stages – ﬁbrosis, cirrhosis and HCC – is
still a major clinical need [4].
Over the past two decades, molecular targets and networks
have increasingly gained attention [8,9], in particular due to theJournal of Hepatology 20
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tion of large scale molecular analysis platforms [12]. As a result,
human and many other genomes, transcriptomes, proteomes
and resources from many other biological layers are publicly
available. This vast amount of molecular data provides a rich
source to better understand the molecular basis of chronic liver
diseases, and to identify novel genomic targets for therapeutic
intervention. However, in order to utilize this information,
knowledge of the available database resources and bioinformat-
ics tools is indispensable.
Data can be deposited in general or speciﬁc databases. In
general databases such as the NIH-hosted PubMed [13], OMIM
[13], or GAD [14], searching speciﬁc information on chronic liver
diseases may still be time-consuming and result in a non-
comprehensive overview. In addition, general databases, e.g.
PubMed [13], lack speciﬁc, hepatology-centered search options
and thus searching liver disease speciﬁc data remains elusive.
In contrast, specialized databases with a focus on speciﬁc
chronic liver diseases lack comprehensiveness or validity of
curated data due to automated data curation, but offer the
option of very detailed and specialized data retrieval, and thus
are a valuable resource in hepatology research. Therefore, the
currently available databases supporting research on liver
diseases are summarized in this review. Furthermore, short
summaries of their focus and applications in hepatology are
provided.General databases holding information on liver diseases
PubMed, PubMatrix, OMIM – mining biomedical literature
PubMed is a major resource of the available biomedical litera-
ture, maintained by the National Center for Biotechnology
Information (NCBI); it currently comprises over 24 million cita-
tions for biomedical literature from MEDLINE, life science jour-
nals, and online books [13]. A useful tool to extract from
PubMed organ- or disease-speciﬁc information, e.g. information
on liver diseases, is Pubmatrix. Using available abstracts in
PubMed, this web-based tool performs automated keyword
searches for co-occurring terms such as speciﬁc gene names
and diseases [15]. The Online Mendelian Inheritance in Man
(OMIM) database, a compendium of human genes and genetic
phenotypes, provides also genetics centered summaries of a
large collection of diseases, including most chronic liver
diseases [13].15 vol. 62 j 712–719
Key Points
• Multiple databases serve as profound knowledge bases 
and provide significant support to molecular research in 
liver disease development and drug targeting
• These resources are not yet connected. However, a 
better connection of the available databases would 
certainly be desirable and holds potential prospects 
for further advances in understanding the molecular 
changes in liver disease
• Bioinformatics and data base resources for liver cancer 
are the best developed tools in hepatology
• Other areas in hepatology, such as viral hepatitis or liver 
fibrosis need significant support for the development 
of more advanced bioinformatics resources. The 
development in oncology may serve as an example of 
how to develop these resources
• Availability and easy access to pre-processed molecular 
high throughput data and the development of graphical 
outputs for hepatology-related data queries will further 
help to extend the use of publicly available data
JOURNAL OF HEPATOLOGYGenetic Association Database (GAD)
The Genetic Association Database provides a collection of data on
genetic association studies. Available data may be searched in
various ways. With respect to liver diseases, the most relevant
search option is the disease phenotypes mode. The listed, search-
able diseases include many chronic liver diseases [14].
GWAS central
Genetic changes associated with liver diseases may be obtained
from GWAS central, a centralized repository of genetic associa-
tion studies. Searching data by means of phenotypes offers multi-
ple options for liver disease-related searches. Top ranked genetic
changes from each displayed analysis can be downloaded for fur-
ther bioinformatics or wet-lab analysis [16].
Gene Expression Omnibus (GEO) proﬁles, Oncomine, ArrayExpress –
mining gene expression microarray data
Gene expression microarray data are available from multiple
public and commercial databases. The most widely used array
repositories are Gene Expression Omnibus (GEO) Proﬁles,
Oncomine, and ArrayExpress. The GEO Proﬁles database provides
graphic gene expression proﬁles derived from microarray exper-
iments stored at NCBI’s GEO microarray resource [17]. These pro-
ﬁles are displayed as bar charts and searchable by means of full
text search. Therefore, by entering liver diseases as search terms,
the database returns graphic results of differential gene expres-
sion in multiple gene expression experiments.
The commercial microarray data repository Oncomine holds
gene expression proﬁles of thousands of cancer patient genomes.
The database offers free differential expression searches for single
genes across different experiments, displaying expression levels
in all samples within a given dataset. Searching multiple genes
and gene expression proﬁles is limited to the commercial licenseJournal of Hepatology 201of the database. With respect to hepatology, the data repository
contains multiple microarray experiments on hepatocellular
and cholangio carcinoma.
The European microarray resource Array Express and its
graphical phenotype-based expression proﬁler Array Atlas, cur-
rently does not contain a considerable amount of data on liver
diseases that can be extracted easily. Thus, the large collection
on microarray data with a focus on liver diseases, is for the most
part accessible only to researchers with advanced bioinformatics
knowledge [18].
Tissue-speciﬁc Gene Expression and Regulation (TiGER)
The TiGER database contains tissue-speciﬁc gene expression
proﬁles or expressed sequence tag (EST), cis-regulatory module
(CRM), and combinatorial gene regulation data. Among the
multiple search options, the database may be searched for genes
preferentially expressed in liver, CRM detections in liver, or pairs
of transcription factors co-regulated in liver tissue [19].
RNA-Seq Atlas
RNA-Seq Atlas is a web-based repository of RNA-Seq gene
expression proﬁles and query tools. The database may be used
to compare tissues and ﬁnd genes with speciﬁc expression pat-
terns. It offers liver speciﬁc gene search options. All data are
linked to common functional and genetic databases, offering in
particular information on genes, signaling pathway analysis and
evaluation of biological functions by means of gene ontologies.
Additionally, data are linked to several microarray gene proﬁles,
including BioGPS normal tissue proﬁles and NCI60 cancer cell line
expression data [20].General liver physiology
The Liver Speciﬁc Gene Promoter Database (LSPD)
The Liver Speciﬁc Gene Promoter Database (LSPD) provides a
collection of liver speciﬁc genes and their regulatory elements.
Information on these regulatory elements is primarily
sequence-based. It may be searched in multiple ways, including
by querying for known regulatory elements, and allow retrieving
promoter sequences. It also offers query options to discover novel
motifs or build promoter models. Finally, the database provides
insights into interactions among known transcriptions factors
expressed in liver.
Liverbase
Based on a large-scale analysis effort of the Chinese human liver
proteome project (CNHLPP), Liverbase contains extensive
knowledge on the human liver proteome. It provides key protein
information such as protein function, abundance, and subcellular
localization. This information is linked to disease speciﬁc
information. Through an intuitive web-interface, the database may
be searched by disease, but also offers queries centered on pathway
or gene ontology. In addition, the database holds information on
the liver transcriptome from Chromatin Immunoprecipitation
DNA Sequencing (CHIP-Seq) and Massively Parallel Signature
Sequencing (MPSS) experiments [21].5 vol. 62 j 712–719 713
Table 1. Summary of the currently available bioinformatics and database resources in hepatology.
Database URL Ref.
General databases holding information on liver diseases
Pubmed http://www.ncbi.nlm.nih.gov/pubmed [13]
Pubmatrix http://pubmatrix.grc.nia.nih.gov [15]
OMIM http://www.ncbi.nlm.nih.gov/omim [13]
Genetic Association database (GAD) http://geneticassociationdb.nih.gov [14]
GWAS central http://www.gwascentral.org [16]
Gene Expression Omnibus (GEO) profiles http://www.ncbi.nlm.nih.gov/geoprofiles [17]
Oncomine https://www.oncomine.org
ArrayExpress http://www.ebi.ac.uk/arrayexpress [18]
Tissue-specific Gene Expression and Regulation 
(TiGER)
http://bioinfo.wilmer.jhu.edu/tiger [19]
RNA-Seq Atlas http://medicalgenomics.org/rna_seq_atlas [20]
General liver physiology
The Liver Specific Gene Promoter Database (LSPD) http://rulai.cshl.edu/LSPD
Liverbase http://liverbase.hupo.org.cn [21]
Mouse liver protein database http://proteome.biochem.mpg.de/liver [23]
Liver disease specific databases
Library of Molecular Associations (LOMA) http://medicalgenomics.org/loma [24]
JAX-Mice database-Liver defects http://jaxmice.jax.org/list/ra102.html
Toxic liver disease
LiverTox http://livertox.nih.gov
Liver Toxicity Knowledge Base (LTKB) http://www.fda.gov/ScienceResearch/BioinformaticsTools/
LiverToxicityKnowledgeBase
[25]
Viral hepatitis-General
The Hepatitis Virus Database http://s2as02.genes.nig.ac.jp [26]
VirusMINT http://mint.bio.uniroma2.it/virusmint [27]
Virus hepatitis B
HepSEQ http://www.hepseq.org [28]
HBVRegDB http://lancelot.otago.ac.nz [29]
Oxford HBV Automated Subtyping Tool http://www.bioafrica.net/rega-genotype/html/subtypinghbv.html [30]
HBV STAR http://www.vgb.ucl.ac.uk/starn.shtml [31]
jpHMM http://jphmm.gobics.de/submission_hbv [32]
HBVseq http://hivdb.stanford.edu/HBV/HBVseq/development/HBVseq.html [33]
SeqHepB http://www.seqhepb.com [34]
Viral hepatitis C
The HCV database at the Los Alamos National Laboratory http://hcv.lanl.gov [35,36]
Oxford HCV Subtyping Tool http://www.bioafrica.net/rega-genotype/html/subtypinghcv.html [30]
Virus Pathogen Database and Analysis Resource (ViPR) http://www.viprbrc.org/brc/home.spg?decorator=flavi_hcv [37]
euHCVdb,European HCV database http://euhcvdb.ibcp.fr [38]
HCVpro, Hepatitis C virus protein interaction database http://cbrc.kaust.edu.sa/hcvpro [39]
Hep-Druginteractions.org http://hep-druginteractions.org
Hepatocellular carcinoma
OncoDB.HCC http://oncodb.hcc.ibms.sinica.edu.tw [40]
Encyclopedia of Hepatocellular Carcinoma Online gene 
(EHCO)
http://ehco.iis.sinica.edu.tw [41]
CellMinerHCC http://medicalgenomics.org/cellminerhcc [42]
Integrated Clinical Omics Database (iCOD) http://omics.tmd.ac.jp/icod_pub_eng/portal/top.do [43]
The Cancer Genome Atlas (TCGA) http://cancergenome.nih.gov [44]
International Cancer Genome Consortium (ICGC) https://icgc.org [45]
ReviewMouse liver protein database
The mouse liver proteome database is based on mass spectrom-
etry analysis of mouse liver tissue. It lists proteins with at least714 Journal of Hepatology 201two peptides identiﬁed in mass spectrometry. This information
was combined with the previously reported organelle map [22].
Through a public web-interface, the database may easily be
searched by means of protein name, peptide sequence, IPI5 vol. 62 j 712–719
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accession, but also using BLAST to compare novel protein
sequences to protein entries present the database [23].Liver disease speciﬁc databases
Library of Molecular Associations (LoMA)
The Library of Molecular Associations (LoMA) is based on
PubMed-published abstracts and aims at closing the gap between
genome-wide coverage of low validity from microarray data and
individual highly-validated data from PubMed. After an initial
automated text mining process, the extracted abstracts were all
manually validated. The database holds conﬁrmed molecular
associations for chronic liver diseases such as HCC, CCC, liver
ﬁbrosis, NASH/fatty liver disease, AIH, PBC, and PSC. The database
may be searched not only by means of disease or gene names, but
also using pathway or gene ontology information provided by the
LoMA database [24].
JAX-Mice database – liver defects
The Jackson Laboratory, harboring one of the largest collections
of gene modiﬁed mouse strains, provides a detailed overview of
mouse strains related to liver speciﬁc phenotypes. For each
mouse model, a short summary on the speciﬁc gene function
and resulting phenotype are given.Toxic liver disease
LiverTox
Database resources for toxic liver disease remain limited. How-
ever, the National Institute of Diabetes and Digestive and Kidney
Diseases in collaboration with the National Library of Medicine
and the Drug-Induced Liver Injury Network study group have
established LiverTox, a comprehensive clinical information
website on drug-induced liver injury. The website provides an
overview of multiple drugs (its chemical nature, indications, rec-
ommended doses and regimens, and frequency of use), followed
by a detailed summary of the pattern and course of the associated
liver injury, and related PubMed references.
Liver Toxicity Knowledge Base (LTKB)
Since liver toxicity is the most common cause for the discontin-
uation of clinical trials and an approved drug’s withdrawal from
sales, Liver Toxicity Knowledge Base collects and summarizes
mechanisms of toxicity, drug metabolism, histopathology,
therapeutic use, targets, side effects, etc. This information is
linked to information on individual drugs, and the use of systems
biology analysis to assess and predict drug-induced liver injury.
Importantly, both conventional and high-throughput molecular
biomarker assays will be conducted for selected drugs to develop
novel biomarkers based on knowledge acquired from the
project [25].Viral hepatitis – general
Viral mutations may accumulate during chronic infection or in
response to external pressure. Resulting drug resistance orJournal of Hepatology 201vaccine escape mutants have become a major concern for the
treatment of individual patients with viral hepatitis, but also in
general for public health. Therefore, bioinformatics algorithms
and databases focusing on viral genetic mutation or recombina-
tion are a major aid to identify those genetic changes and to
successfully target the resulting liver disease.
The Hepatitis Virus Database
The Japanese Hepatitis Virus Database holds information on
diverse hepatotropic viruses. This repository mainly provides
resources as a phylogenetic analysis of publicly HBV, HCV, and
HEV sequences, both nucleic acid and protein sequences [26].VirusMINT
A detailed understanding of the molecular interactions between
host physiology and viral infection will certainly be a major aid
in targeting viral hepatitis. The VirusMINT database provides a
comprehensive summary of protein interactions between viral
and human proteins reported in the literature. Among the differ-
ent viral strains provided are information on viral hepatitis B and
C. Virus-speciﬁc search pages offer easy query options, and
results provided by the database can be displayed with a graph-
ical viewer [27].Viral hepatitis B
For HBV research, several genomic databases have been estab-
lished to investigate and monitor the genetic variability of HBV
sequences and viral resistance to treatment. These databases
may aid in the development of new diagnostic reagents as well
as in the monitoring of polymerase and envelope protein muta-
tions selected under different antiviral treatments.HepSEQ
HepSEQ is a collection of sequence, clinical and epidemiological
data related to hepatitis B virus (HBV) infection. The data were
collected from patients of 40 different nationalities and diverse
ethnic backgrounds, and are quality-controlled. Upon registra-
tion, they may be accessed through a web front-end allowing
search and manipulation of the stored data, but also extraction
and visualization of information on epidemiological, virological,
clinical, nucleotide sequence and mutational aspects. Additional
bioinformatics tools provide further information on HBV geno-
type, identify mutations with known clinical signiﬁcance (e.g.
vaccine escape, precore and antiviral-resistant mutations), and
carry out sequence homology searches against other deposited
strains [28].
HBVRegDB
HBVRegDB combines multiples NCBI reference sequence annota-
tions of the HBV genome with comparative analysis tools such as
blastn, a standard sequence alignment tool. Major strength of the
database is its graphic presentation of the results, which uses the
generic genome browser (GBrowse) adapted for the analysis of
viral genomes [29].5 vol. 62 j 712–719 715
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Oxford HBV automated subtyping tool
More recently, genotyping algorithms that implement a sliding
window to generate multiple overlapping segments of a query
sequence and its reference dataset, have been developed for
HBV. The resulting shorter sequence pieces are individually ana-
lyzed and afterwards assembled to obtain the full sequence anal-
ysis. This procedure increases the accuracy and reliability of the
results, especially when analyzing recombinant viruses. The algo-
rithm allows analysis of up to 1000 sequences simultaneously; it
is available on several webservers, among which the Bioafrica
server [30].
HBV STAR
Comparable to the above-mentioned algorithm, HBV STAR
performs sequence analysis and genotyping by using a sliding
window of 150 bp with a step interval of one base. The underly-
ing algorithm generates position-speciﬁc scoring matrices, which
allow the analysis of subgenomic sequences as the basis of
sequence comparison and the identiﬁcation of potential recombi-
nants (if sequences are divergent more than 1% from ascribed
genotypes). A web interface to HBV STAR is available [31].jpHMM
Similar to the above-described algorithms, Schultz et al. imple-
mented a genotyping algorithm that may indentify and describe
intersubtype recombinations using a probabilistic approach, the
so-called jumping proﬁle Hidden Markov Model (jpHMM). This
algorithm models the most likely subtype at each nucleotide,
thereby being able to identify diverse subtypes and recombina-
tions in one sequence. The jpHMM algorithm is also available
through a web interface [32].
HBVseq
In addition to subtype analyses of a sequence query, the HBVseq
uses information from a local HBV drug resistance database
(HBVrt DB) to retrieve the prevalence of each mutation according
to genotype and treatment [33].
SeqHepB
Similar to HBVseq, SeqHepB is a commercial database that deter-
mines the HBV genotype and aims at identifying key viral muta-
tions associated with antiviral resistance [34].Viral hepatitis C
Six genotypes of the hepatitis C virus (HCV) have been established
that differ in treatment response. However, on the basis of nucle-
otide sequences many more additional subtypes may be charac-
terized. The high sequence variability may very well be involved
in escape and resistance mutations of the virus. Over the past dec-
ade, as an accompanying effort of the development of increasingly
effective drugs targeting the virus, several HCV speciﬁc databases
have been established with the aim of collecting HCV sequences
as well as structural and functional analyses of the virus.716 Journal of Hepatology 201The HCV database at the Los Alamos National Laboratory
The HCV database at the Los Alamos National Laboratory (USA)
contains manually annotated sequence information (HCV
sequence database) and information on immunological epitopes
(HCV immunology database). The HCV sequence database allows
diverse search options for HCV sequences, in particular for
sequence length or speciﬁc regions of interest. Furthermore,
user’s sequence results may be incorporated and subject to
sequence comparisons (e.g. for similarity, principal coordinate
analysis, and others), or phylogenetic analyses. Search results
may be aligned using implemented alignment tools. Noteworthy,
a unique geographic tool provides pie charts of the numbers of
sequences of each genotype on geographical maps [35,36].
Oxford HCV subtyping tool
Comparable to the HBV subtyping tool described above, an HCV
analysis algorithm was also implemented by the same group.
Again, a sliding window generates multiple overlapping seg-
ments of a query sequence and its reference dataset. These
shorter pieces of sequence are individually analyzed and in a
second step assembled to obtain the full sequence analysis. The
algorithm is available through a public webserver [30].
Virus Pathogen Database and Analysis Resource (ViPR)
The Virus Pathogen database and Analysis Resource (ViPR) con-
tains major information and bioinformatics tools for HCV
research. It provides a large collection of sequence genetics and
protein sequence information, but also data on three-dimen-
sional protein structures, immune epitopes, or host factors. Infor-
mation retrieved from the comprehensive database may then
directly be subject to further analysis via advanced bioinformat-
ics algorithms such as alignment tools, BLAST searches, phyloge-
netic comparisons or three-dimensional visualizations of protein
structures [37].
euHCVdb, European HCV database
TheEuropeanHCVdatabase offers access to a computer-annotated
set of sequences and molecular models of HCV proteins, and
focuses on protein sequence, structure and function analysis. It is
composed of two parts, static and dynamic part. The static part
provides access to multiple pre-computed reference sequences
and alignments, but also three-dimensional protein structures.
Bioinformatics interfaces such as Jmol or alignment tools allow
comparison and visualization of these sequence and molecules.
The dynamic part of thewebsite allows submitting speciﬁc queries
using selections from a pre-deﬁned query interface, containing
multiple parameters for each speciﬁc query. Finally, three-dimen-
sional proteinmodels for variants not yet available in the database
can be built with the Geno3DWeb server [38].
HCVpro, hepatitis C virus protein interaction database
The HCVpro database provides manually veriﬁed hepatitis C
virus–virus and virus–human protein interactions curated from
literature and databases. The available data were extracted from
different sources among them euHCVdb, HCVdb, or VirusMint,
but also other protein interaction resources such as BIND and5 vol. 62 j 712–719
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other relevant biology repositories. Besides pure protein interac-
tion, proteins curated in HCVpro have also been extensively
cross-referenced to other essential bioinformatics annotations,
in particular gene ontologies, canonical pathways, or Online Men-
delian Inheritance in Man (OMIM). Finally, HCVpro holds summa-
ries on structure and functions of HCV proteins and current state
of drug and vaccine development, and links references [39].
Hep-Druginteractions.org
Differently from databases summarizing molecular knowledge
on disease development, Hep-Druginteractions.org summarizes
recent developments on novel antiviral substances and their
obvious drug interactions to multiple know substances. Hep-
Druginteractions.org illustrates these interactions by providing
a printable chart of the currently known drug interactions as well
as an Internet-based search tool. The interactions may be
searched as an alphabetical list of drugs or by drug classes. As
an output, the Internet-based knowledge base returns informa-
tion on drugs that should not be co-administered or may have
potential interactions.Hepatocellular carcinoma
OncoDB.HCC
OncoDB.HCC provides detailed bioinformatics resources for HCC
research by integrating data from a wide variety of genomic aber-
ration studies. These data include chromosomal aberration studies
from loss of heterozygosity (LOH) and comparative genome
hybridization (CGH) analysis as well as altered gene expression
data from microarray and proteomic studies. Data were collected
from public databases such as PubMed, journals of the NCBI liter-
aturedatabase and the StanfordMicroarrayDatabase. The intuitive
web interface offers several comprehensive search options. The
genomic aberration search displays a graphic overview on human
and rodent QTLs, or genetic loci associatedwithHCC development.
In expression view, a total of 9785 genes may be searched for a
potential involvement in HCC development. In addition, the HCC
signiﬁcant search option offers a summary of 614 genes and their
associationwith several lines of evidence such as microarray data,
RT-PCR, QPCR, IHC, Western blot, and others [40].
Encyclopedia of Hepatocellular Carcinoma Online gene (EHCO)
Encyclopedia of Hepatocellular Carcinoma Online gene (EHCO) is
an integrative platform collecting, organizing and comparing
systematically unsorted HCC-related studies by using natural lan-
guage processing as well as individual and manual validation.
Currently, two versions of EHCO are available, a 2007 version
and a 2008 version. The 2008 version (EHCO II) contains 13 gene
sets related to HCC from several diverse technological platforms
such as PubMed, SAGE, microarray analysis as well as proteomics
data. Data from these sources were extracted in an automated
fashion using intelligent software robots. The 2008 version
contains 4020 genes in total; however, most genes are only
included once (65%), suggesting that tremendous efforts need to
be exerted to further validate these automatically obtained genes
and to characterize the relationship between HCC and these
genes. Genes associated to HCCmay be searched bymultiple iden-
tiﬁers such as Gene Symbol, UniGene ID, Entrez Gene ID, orJournal of Hepatology 201Ensembl ID. In addition, the website offers a full list of genes, a ref-
erence to the dataset in which a gene is found differentially
expressed, and provide counts of the number of datasets where
an up- or down-regulation of the speciﬁc gene is reported [41].
CellMinerHCC
CellMinerHCC is a publicly available database containing micro-
array expression proﬁles of diverse HCC cell lines. At present, this
database holds genome wide microarray proﬁles of 18 HCC cell
lines. The database allows the evaluation of expression proﬁles
of individual HCC cell lines and the comparison of differential
gene expression betweenmultiple cell lines. Evaluation of cell line
expression proﬁles and their differences is supported via a public
web interface that provides easy access to microarray data [42].
Integrated Clinical Omics Database (iCOD)
The iCOD database is an Integrated Clinical Omics Database
(iCOD) containing molecular omics data such as CGH
(comparative genomic hybridization) and gene expression
proﬁles, and also comprehensive clinical information such as
clinical manifestations, medical images, laboratory tests, or drug
histories from 140 patients with HCC. The iCOD database may
therefore be a major aid in linking molecular omics data and
disease pathways to clinico-pathological ﬁndings. A major
strength of the database is certainly the strong link to numerous
clinical data. On the downside, results from the database are hard
to extract for further analyses [43].The Cancer Genome Atlas (TCGA)
Under the lead of the National Cancer Institute and the National
Human Genome Research Institute, The Cancer Genome Atlas
(TCGA) database has developed into a massive and powerful data
resource. It contains data on a large number of patients and for
many of them data on multiple biological levels such as copy
number variation, gene expression, miRNA expression, or meth-
ylation status. For most of the samples, control tissue/normal tis-
sue data are available to compare the cancerous tissue with. The
TCGA Data Portal allows to ﬁlter the available data for a cancer of
interest and to select manually the data ﬁles of interest. Major
advantage of the database is the availability of comprehensive
data on multiple biological layers. However, to obtain and ana-
lyze the data, advanced bioinformatics skills are necessary as
most data provided are unprocessed raw data from the original
experiments [44].
International Cancer Genome Consortium (ICGC)
The International Cancer Genome Consortium (ICGC) was
launched to coordinate large-scale cancer genome studies in
tumors from 50 different cancer types and/or subtypes that are
of clinical and societal importance across the globe. Hepatocellular
carcinoma is found among the tumors studied in this consortium.
The consortium’s data hub currently hosts ﬁve large-scale experi-
ments and analyses on genomics, transcriptomics, and epigenetics
of hepatocellular carcinoma. The underlying diseases vary from
alcoholic liver disease to viral hepatitis based liver cirrhosis.
Patients were collected in China, Japan, France, and USA. Strength
of the database is its comprehensive data on multiple biological5 vol. 62 j 712–719 717
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layers. However in order to obtain and analyse the data advanced
bioinformatics skills are necessary as most data provided are
unprocessed raw data from the original experiments [45].Discussion
Promoted by the decoding of the human genome as part of the
human genome project, bioinformatics algorithms and database
resources have become a major aid for the analysis of molecular
changes leading to chronic liver disease, cirrhosis and cancer.
With the aim of expanding the current knowledge underlying
disease mechanisms and treatment options, but also to identify
and characterize biomarkers, the creation of genetic ﬁngerprints
for individualized diagnosis, prognosis and treatment of patients
has shifted to the center of interest in translational hepatology.
Furthermore, recently developed high-throughput analysis tech-
nologies rely essentially on sufﬁcient bioinformatics databases
and build expectations for more effective, less prone to side
effects, and economically reasonable therapies. The challenges
of the next few years relate to the broadening of the knowledge
base, the establishment of reliable and standardized technologies,
and the development of intelligent bioinformatics strategies for
data analysis and data integration. In contrast to other ﬁelds in
medicine, e.g. cancer biology, the availability of specialized bioin-
formatics resources and databases remains limited. However, the
potential of powerful bioinformatics resources can nicely be illus-
trated with the example of hepatocellular carcinoma, which is
efﬁciently covered by multiple efforts in the context of cancer
biology [8].
If for example one wants to estimate the role of a given gene
in HCC biology, multiple database resources may provide sub-
stantial information to assemble the full picture of transcriptional
regulation. First LoMA [29] holds published molecular
associations of liver cancer and genetic regulations. If not listed
in LoMA, the gene may further be analyzed by means of Pubma-
trix [15] matching the gene name against key biological terms
such as ‘‘cancer’’, ‘‘liver carcinogenesis’’, or ‘‘HCC’’. Transcriptomic
changes may then be obtained from GEO proﬁles using ‘‘HCC’’ or
‘‘liver cancer’’ as search terms; GEO proﬁles would provide graph-
ical illustrations of differential regulations found in microarray
experiments stored in the GEO microarray database [17]. Finally,
differential gene expression may be linked to clinical course of
disease using the iCOD database [43]. Entering a gene name,
the database provides information on gene expression from 60
patients and links the gene expression to clinical parameters such
as tumor size, TNM stage, AFP level, survival and others. A Stu-
dent’s t-test is performed to estimate the statistical relevance.
The most comprehensive data are provided by the ICGC [44]
and TCGA [45] projects. These projects offer clinical data com-
bined with comprehensive molecular data, not only on gene
expression, but also genetic and epigenetic information. If capa-
ble of performing the bioinformatics analysis, these resources
offer to assemble a complete picture of the inﬂuence of genomics,
transcriptomics or epigenetics changes for the development and
clinical course of hepatocellular carcinoma.
Having illustrated the in silico options in liver cancer biology,
the shortcomings in other aspects of chronic liver disease become
obvious. For example, searching for a gene’s role in viral hepatitis
biology remains difﬁcult, if not impossible. The currently
available bioinformatics resources focus on identifying viral
subtypes or genetic changes within the viral genome, but offer718 Journal of Hepatology 201no insights on the role of particular genes in host biology. Simi-
larly, the options in investigating the role of a gene in liver ﬁbro-
sis remain limited. Besides few microarray experiments available
from the GEO [17] or ArrayExpress [18] databases and mostly
performed in mice, there is currently no option to estimate a gene
function in ﬁbrosis development.
Overall, multiple database resources have been established
over the past years (Table 1). However, their development is far
behind other areas of clinical medicine such as oncology. Further
development of bioinformatics and database resources in hepa-
tology will certainly be essential to progress further in unraveling
the molecular changes in liver disease.
In order to develop bioinformatics and database resources in
hepatology, the recent developments in oncology may serve as
an example. The ﬁrst step to take will be the establishment of a
comprehensive knowledgebase unifying the multiple available
bioinformatics tools. Next, the integration of available microarray
data in a hepatology speciﬁc repository and the graphical
illustration of the data, e.g. for differential gene expression, will
certainly help make these data available to the hepatologic
community without requiring advanced bioinformatics
knowledge. Finally, large-scale and multi-institutional efforts will
be needed to collect samples and data for comprehensive
databases in ﬁelds of hepatology other than liver cancer, in
particular liver ﬁbrosis and viral hepatitis.Conclusions
Multiple databases offer a wide range of speciﬁc and mostly com-
prehensive resources for hepatology research. They may serve as
profound knowledge bases, but also provide signiﬁcant support
to molecular research in liver disease development and drug
targeting. However, it would a certainly be desirable to further
develop the available databases and to better connect them, since
this may hold potential prospects for further advances in under-
standing the molecular changes in liver disease.Conﬂict of interest
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